Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Verona initiates phase IIb study of nebulized ensifentrine in moderate to severe COPD

May 7, 2019

Novel selective PI3Kgamma inhibitors induce specific conformational changes

May 7, 2019

Phase III study of Trelegy Ellipta in uncontrolled asthma meets primary endpoint

May 3, 2019

Kalydeco approved in U.S. for infants from 6 months with cystic fibrosis

May 2, 2019

Maruishi reports results from Japanese phase III study of Traumakine in ARDS

April 29, 2019

RTD-1 shows promising preclinical results in mouse model of cystic fibrosis

April 17, 2019

First-in-human data for PLN-74809 support development of the candidate for the treatment of IPF

April 10, 2019

Prenatal treatment improves cystic fibrosis

April 3, 2019

FDA approves Duaklir for maintenance treatment of COPD

April 1, 2019

Chiesi Farmaceutici presents ROCK1 and ROCK2 inhibitors

April 1, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...